PATRICE CIANFROCCO: Open Payments
NPI 1891248803 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 27 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 5 | $105 |
| Electromed, Inc. | 4 | $98 |
| Grifols USA, LLC | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $21 |
Products named: Ohtuvayre, SMARTVEST, Prolastin-C Liquid, XYWAV, ZEPBOUND, CREXONT, INGREZZA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
